We evidence that FOXO1 activity can be pharmacologically modulated to recover muscle homeostasis in ALS cells and to improve the neuromuscular function in ALS Drosophila models with muscle-specific TDP-43 and FUS silencing. The gene discussed is FOXO1; the disease is amyotrophic lateral sclerosis.